Literature DB >> 3185627

Gentamicin volumes of distribution in patients with hematologic disorders.

J K Phillips, R L Spearing, D J Crome, J M Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3185627     DOI： 10.1056/NEJM198811103191918

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ tumours.

Authors:  A Ortega; A Aldaz; J Giráldez; A Brugarolas
Journal:  Pharm World Sci       Date:  1999-10

2.  Gentamicin pharmacokinetics, nephrotoxicity, and prediction of mortality in febrile neutropenic patients.

Authors:  T M Bianco; P N Dwyer; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

3.  Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.

Authors:  R J Tomlinson; M Ronghe; C Goodbourne; C Price; J S Lilleyman; S Das; V Saha
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

4.  Gentamicin pharmacokinetics in patients with malignancies.

Authors:  J S Bertino; L A Booker; P Franck; B Rybicki
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

5.  Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.

Authors:  R L Davis; D Lehmann; C A Stidley; J Neidhart
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

6.  Population pharmacokinetics of gentamicin in patients with cancer.

Authors:  M C Rosario; A H Thomson; D I Jodrell; C A Sharp; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.